X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs DISHMAN PHARMA - Comparison Results

LUPIN    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN DISHMAN PHARMA LUPIN/
DISHMAN PHARMA
 
P/E (TTM) x 40.8 25.1 162.7% View Chart
P/BV x 2.5 3.3 74.7% View Chart
Dividend Yield % 0.7 0.7 100.0%  

Financials

 LUPIN   DISHMAN PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-18
DISHMAN PHARMA
Mar-16
LUPIN/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,465374 391.3%   
Low Rs727129 564.1%   
Sales per share (Unadj.) Rs349.6197.8 176.7%  
Earnings per share (Unadj.) Rs5.621.2 26.2%  
Cash flow per share (Unadj.) Rs29.634.7 85.2%  
Dividends per share (Unadj.) Rs5.002.00 250.0%  
Dividend yield (eoy) %0.50.8 57.4%  
Book value per share (Unadj.) Rs300.3179.9 166.9%  
Shares outstanding (eoy) m452.0880.69 560.3%   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x3.11.3 246.4%   
Avg P/E ratio x197.211.9 1,661.8%  
P/CF ratio (eoy) x37.17.2 511.3%  
Price / Book Value ratio x3.61.4 260.9%  
Dividend payout %90.09.4 953.9%   
Avg Mkt Cap Rs m495,50220,306 2,440.2%   
No. of employees `00017.00.8 2,055.7%   
Total wages/salary Rs m28,6475,355 535.0%   
Avg. sales/employee Rs Th9,273.619,252.7 48.2%   
Avg. wages/employee Rs Th1,681.06,459.5 26.0%   
Avg. net profit/employee Rs Th147.42,064.1 7.1%   
INCOME DATA
Net Sales Rs m158,04215,961 990.2%  
Other income Rs m1,504265 566.5%   
Total revenues Rs m159,54516,226 983.3%   
Gross profit Rs m31,4754,103 767.1%  
Depreciation Rs m10,8591,091 995.7%   
Interest Rs m2,044944 216.4%   
Profit before tax Rs m20,0762,334 860.3%   
Minority Interest Rs m-710-   
Prior Period Items Rs m351 3,200.0%   
Extraordinary Inc (Exp) Rs m-14,6440-   
Tax Rs m2,885624 462.6%   
Profit after tax Rs m2,5131,711 146.8%  
Gross profit margin %19.925.7 77.5%  
Effective tax rate %14.426.7 53.8%   
Net profit margin %1.610.7 14.8%  
BALANCE SHEET DATA
Current assets Rs m122,09511,018 1,108.2%   
Current liabilities Rs m50,9569,517 535.4%   
Net working cap to sales %45.09.4 478.7%  
Current ratio x2.41.2 207.0%  
Inventory Days Days85110 76.6%  
Debtors Days Days12035 344.2%  
Net fixed assets Rs m129,87616,304 796.6%   
Share capital Rs m904161 560.2%   
"Free" reserves Rs m134,86612,907 1,044.9%   
Net worth Rs m135,77114,516 935.3%   
Long term debt Rs m64,2454,189 1,533.5%   
Total assets Rs m263,05429,805 882.6%  
Interest coverage x10.83.5 311.9%   
Debt to equity ratio x0.50.3 164.0%  
Sales to assets ratio x0.60.5 112.2%   
Return on assets %1.78.9 19.4%  
Return on equity %1.911.8 15.7%  
Return on capital %3.717.5 21.2%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m53,1414,952 1,073.2%   
Fx outflow Rs m19,335697 2,774.8%   
Net fx Rs m33,8074,255 794.6%   
CASH FLOW
From Operations Rs m17,5122,786 628.5%  
From Investments Rs m-14,073-1,529 920.4%  
From Financial Activity Rs m-14,921-941 1,585.5%  
Net Cashflow Rs m-11,482316 -3,628.9%  

Share Holding

Indian Promoters % 46.6 61.4 75.9%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 3.7 305.4%  
FIIs % 31.9 12.7 251.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 22.1 45.7%  
Shareholders   98,259 46,261 212.4%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   UNICHEM LAB  AUROBINDO PHARMA  IPCA LABS  GLENMARK PHARMA  VENUS REMEDIES  

Compare LUPIN With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

US China Trade War Escalations and Election Results: Volatility Set to Rule(Podcast)

India could be the latest direct victim of the US-China trade war. The increasing escalations have already slowed down global growth.

Related Views on News

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

LUPIN LTD Announces Quarterly Results (1QFY19); Net Profit Up 21.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, LUPIN LTD has posted a net profit of Rs 4 bn (up 21.3% YoY). Sales on the other hand came in at Rs 26 bn (up 3.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

These Dividend Stocks Could Boost Your Returns Better Than You Can Imagine(Profit Hunter)

May 7, 2019

The art of dividend investing is a lot more than investing in companies with high dividend payouts or stocks with high dividend yields...

Limited Upside, Higher Downside(The Honest Truth)

May 6, 2019

The market's irrational reaction may present opportunities for a limited period of time.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


May 17, 2019 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS